Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kind

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Interferon Research|January 1, 1981
Thymosin treatment modulates production of interferonK Y Huang, P D Kind, E M Jagoda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975
Listeria cell wall fraction: a B cell mitogenJ J Cohen, G E Rodriguez, P D Kind, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1975
Oncornaviral protein modulation in mouse uterine tissue by estrogen (38467)A K Fowler, N M Kouttab, P D Kind, et al.
Cellular Immunology|December 1, 1979
Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicityJ R Ortaldo, R P MacDermott, G D Bonnard, et al.
Infection and Immunity|September 1, 1984
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factorB D Meade, P D Kind, J B Ewell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1984
Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigensJ J Ryan, A Ahmed, P D Kind, et al.
Journal of Biological Response Modifiers|October 1, 1986
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjectsR S Schulof, G L Simon, M B Sztein, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Interferon Research|January 1, 1981
Thymosin treatment modulates production of interferonK Y Huang, P D Kind, E M Jagoda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975
Listeria cell wall fraction: a B cell mitogenJ J Cohen, G E Rodriguez, P D Kind, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1975
Oncornaviral protein modulation in mouse uterine tissue by estrogen (38467)A K Fowler, N M Kouttab, P D Kind, et al.
Cellular Immunology|December 1, 1979
Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicityJ R Ortaldo, R P MacDermott, G D Bonnard, et al.
Infection and Immunity|September 1, 1984
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factorB D Meade, P D Kind, J B Ewell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1984
Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigensJ J Ryan, A Ahmed, P D Kind, et al.
Journal of Biological Response Modifiers|October 1, 1986
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjectsR S Schulof, G L Simon, M B Sztein, et al.
Pageof 2